Clinical Trial Update: Taste Evaluation of Different Liquid Formulations With Eliglustat [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating taste and palatability of different liquid formulations of eliglustat in Gaucher disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• Eliglustat (Eliglustat)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Gaucher Disease | Phase 1 | Status: COMPLETED